Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease
| Autor: | David L. Hahn, James D. Hoehns, Timothy J. Ives, Liz Uribe, Barry L. Carter, Christopher S. Coffey, Maxwell D. Anderegg, Tyler H. Gums, Eric J. MacLaughlin, Oralia V. Bazaldua |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Blood pressure control
Adult Male medicine.medical_specialty Blood Pressure 030204 cardiovascular system & hematology Pharmacists Article 03 medical and health sciences 0302 clinical medicine Internal medicine Diabetes mellitus Physicians medicine Diabetes Mellitus Cluster Analysis Humans Pharmacology (medical) In patient 030212 general & internal medicine Cooperative Behavior Renal Insufficiency Chronic Pharmacist intervention Aged Aged 80 and over business.industry Guideline Middle Aged medicine.disease Blood pressure Mean blood pressure Pharmaceutical Services Hypertension Practice Guidelines as Topic Female Interdisciplinary Communication business Kidney disease |
| ISSN: | 0093-5077 |
| Popis: | OBJECTIVES: The objectives of this study were to 1) determine if hypertensive patients with comorbid diabetes mellitus (DM) and/or chronic kidney disease (CKD) receiving a pharmacist intervention had a greater reduction in mean blood pressure (BP) and improved BP control at 9 months compared to those receiving usual care and 2) compare Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) guideline and 2014 guideline (JNC-8) BP control rates in patients with DM and/or CKD. METHODS: This cluster, randomized trial included 32 medical offices in 15 states. Clinical pharmacists made treatment recommendations to physicians at intervention sites. This post-hoc analysis evaluated mean BP and BP control rates in the intervention and control groups. MAIN RESULTS: The study included 335 patients (227 intervention, 108 control) when mean BP and control rates were evaluated by JNC-7 inclusion and control criteria. When JNC-8 inclusion and control criteria were applied, 241 patients (165 intervention, 76 control) remained and were included in the analysis. The pharmacist-intervention group had significantly greater mean SBP reduction compared to usual care at 9 months (8.64 mm Hg [95% Confidence interval (CI)= −12.8, −4.49, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|